logo
I Know How Risky Sunbeds Are, So Why Can't I Quit Them?

I Know How Risky Sunbeds Are, So Why Can't I Quit Them?

Refinery2902-07-2025
Welcome to Sun Blocked, Refinery29's global call to action to wake up to the serious dangers of tanning. No lectures or shaming, we promise. Instead, our goal is to arm you with the facts you need to protect your skin to the best of your ability, because there's no such thing as safe sun.
'I'll just do a few sessions on a sunbed to build a base tan before my holiday,' I told myself earlier this year. The results weren't instant, unlike the self-tanners I've used for over a decade, but after a few visits, my skin looked golden. I enjoyed the somewhat lasting glow that didn't leave me looking like a slice of tiger bread after four days.
I planned to stop going to the tanning salon once I got back to the UK, but the allure of sunbed-kissed skin was hard to resist. What started as building a holiday base tan — which dermatologists argue is actually a myth — quickly turned into, 'I'll keep going so I'm tanned for my birthday,' then, 'I might as well continue over summer. A few more weeks won't hurt.' Before I knew it, I was clocking up minutes at the tanning salon like points on my Tesco Clubcard. Unlike the money-off coupons I get with my Clubcard, however, there's no long-term benefit to using sunbeds.
But I know this. I know the potentially life-threatening risks of using sunbeds. I know that sunbed use increases the risk of developing skin cancer like melanoma, and that sunbeds cause about 440 melanomas and around 100 deaths each year in the UK, according to research from the charity Melanoma Focus. I'm not alone in knowing the risks. In a UK survey conducted this year, 59% of people admitted they knew that sunbed use increases the risk of skin cancer. Why, then, do we continue?
Dr Ravi Gill, a practitioner psychologist at Smart Mind Health, says that beauty ideals such as ' tanned equals attractive ' can override our instinct for self-protection: 'This is due to powerful social and psychological influences,' says Dr Gill. Adding, 'From a young age, we're exposed to messages — through media, peers and culture — that link tanned skin with attractiveness, status and health. Over time, these ideas are internalised and tied to our self-worth and identity.'
Lisa, 32, can certainly relate. She used a sunbed for the first time at just 17 years old after a friend said it would 'look good' to have tanned skin. 'I was curious, so I decided to give it a try,' she tells me, adding that body insecurities are a reason she still uses them: 'When I'm tanned, the spider veins and cellulite on my legs, which you don't see much of on social media, are less visible,' she says. 'That makes me feel more confident. I get compliments as well, which is motivation to continue.'
Interestingly, tanning isn't the only example of how we're trading safety for self-esteem. This notion can also be applied to many of our aesthetic practices, like unregulated Botox and BBLs, which have a notoriously high mortality rate in comparison to other cosmetic procedures. Shedding light on this, Dr Gill explains that humans crave social acceptance and fear rejection, choosing to conform to beauty norms — even when they involve risks: 'The desire for social belonging and approval often feels more immediate and emotionally powerful than long-term health concerns,' she says.
'
While I think tanning makes me look better in many ways, I feel particularly conflicted about the damage it's doing thanks to my medical history: I've always had a few questionable moles. The fact that I use sunbeds is something I'm quite embarrassed about.
'
Concerningly, Lisa tells me that she fears skin ageing more than skin cancer: 'Ironically, I've curated a social media feed full of skinfluencers teaching me how to look after my skin, and I've honed a [multi-step] skincare routine. Yet I continue to do the one thing that will damage my skin the most — something which no amount of serum or SPF can save me from.'
Lisa's honesty, or as she puts it, 'silliness', might seem extreme to some, but it reveals a deeper truth: decades of messaging have taught us that our value lies in our appearance. Thanks to the popularity of Ozempic alongside the return of thinness on red carpets and For You Pages (which notably prompted the 'skinnytok' hashtag ban), being slim is back on a pedestal — and tanning plays a role here. I've often found myself commenting on how much 'slimmer' I look with a tan, and who can blame me? Shows like Love Island have helped solidify the idea that bronzed skin doesn't just look 'better' but also leaner and more sculpted — like contouring for your whole body.
Is tanning bad for you?
While I think tanning makes me look better in many ways, I feel particularly conflicted about the damage it's doing thanks to my medical history. I've always had a few questionable moles. Some are asymmetric, others have jagged borders and a range of colours. On holiday, when my skin is exposed in a bikini, friends and family have commented on it and encouraged me to get checked out. After spending time living in Australia, where UV levels are very high, I decided to follow through on this. I wasn't a sunbed user at the time of my first (or second) mole check, but doctors did flag that the Sydney sunshine could have put my skin at risk. After an examination of my moles, I was advised to keep an eye on them and return if I saw any 'noticeable changes'.
In the years since those checks, I've observed a handful of changes to some of my moles. But as someone with health anxiety, I never know if I'm being paranoid or if I really should go back to the doctor. Consequently, I'm in limbo — I don't want to waste NHS time if the changes I've seen aren't 'noticeable' enough, but I also don't want to ignore the issue and end up in a potentially life-threatening situation. Taking all of this into consideration, the fact that I use sunbeds probably sounds absurd. Honestly, it's something I'm quite embarrassed about.
Why do we use sunbeds despite the risks?
Dr Gill explains that this is a case of cognitive dissonance, when a person feels psychological discomfort because their actions contradict their beliefs. 'In beauty culture, this dissonance is common,' she says, pointing again societal pressures. 'For example, someone may understand the risks of sunbed use or crash dieting but still engage in these behaviours to align with societal beauty ideals.' Dr Gill goes on to explain that we try to resolve this internal discomfort by rationalising our behaviours rather than changing them. Telling ourselves, 'It's just for summer' or 'Everyone else is doing it' is an easy way to avoid feelings of guilt.
Critics, however, often think that sunbed users should feel guilty for this choice. But here's the thing: 'Shaming people for using sunbeds often backfires, making them more likely to continue the behaviour,' says Dr Gill. She adds, 'Research shows that self-criticism reduces motivation for change, while compassionate, non-judgmental support is more effective in encouraging healthier choices.' But can anyone truly say they've always put their health above all else? Like sunbeds, alcohol, processed meat and tobacco, for example, are classed as type one carcinogens — substances that can cause cancer. I'm keen to know whether those who frown on my habit often indulge in a fast food burger or unwind with a bottle of wine.
'
We are watching the number of skin cancers scale out of control in our clinics.
Dr Kiely
'
Is tanning addictive?
That's before we bring class into the equation. Research that shows those from lower socio-economic backgrounds are more likely to use sunbeds. Although further investigation is needed to explore why that is, a 2022 study concluded that sunbed use has been historically framed through the media as a 'working-class activity'.
Of course, it's not just about class, appearances or a taste for Sauvignon Blanc; the addictiveness of carcinogens plays a role: 'Tanning is addictive and there's actually a biological explanation,' says Dr Clare Kiely, a consultant dermatologist and cofounder of The Skin Diary. She explains that when the body is exposed to UV radiation, it triggers a process that results in the release of endorphins, hormones that create a sense of 'euphoria'. For many, the glow isn't just about looking good — it's about feeling good, too: 'I'm normally in a better mood after a sunbed,' confirms Ella, who agrees this 'mood-boosting' effect is a big factor in why people feel addicted to sunbeds. Lisa echoes this, telling me she enjoys the light and 'me-time' of being on a sunbed: 'It's like dreaming myself away to a beach.'
Given how addictive sunbeds are, the responsibility to prevent their damage shouldn't rest solely on users. Many experts argue that stricter regulation is the only way forward, especially as research shows we continue to tan in spite of the evidence before us. 'I don't believe the current regulations are adequate,' says Dr Rakesh Anand, a consultant dermatologist and British Skin Foundation spokesperson. He notes that while there are restrictions on under-18s and some standards for equipment and usage, there's still a 'significant' public health risk.
'Given the well-established link between sunbed use and skin cancer, stronger measures are urgently needed,' he adds. As for what that might look like, various skin cancer charities have called for sunbeds to have graphic warning signs similar to those found on cigarette packets, while a June 2025 study exposed ' potential gaps in current regulations ' when it comes to tanning salons marketing on social media.
Whether on a sunbed in South London or a beach lounger in Spain, dermatologists are firm in their answer that there's no such thing as a safe tan — 'Unless it's self-tanner from a bottle,' says Dr Kiely. She agrees with Dr Anand that the only way to 'eliminate' risk is to ban sunbeds, as they are in countries such as Australia and Brazil: 'I'm coming at it as a person who has spent her career cutting out thousands of skin cancers, some of them life-threatening,' Dr Kiely adds. 'We are watching the number of skin cancers scale out of control in our clinics. We must take measures now to protect future generations.'
Despite being reminded by every expert of the very real dangers before me, in the time I've been writing this article, I've clocked up another 44 minutes on the sunbeds — although I have reduced the frequency of my visits. I want to stop altogether and pick up my once-beloved self-tanners that are currently collecting dust, but I'm trying to feel less guilt and shame about this habit, as I've unpicked how years of societal pressure led me to this point. Ultimately, that's what needs to change. From Botox to fillers and beyond, we've all been sold on the 'ideal' appearance, which can differ depending on what we've been conditioned into thinking.
The recent ban on disposable vapes proves that if people want to do something, they'll find a way, so we all have to do our part in breaking the cycle when it comes to tanning. Mine is writing this article and being vulnerable about a paradox many of us feel but rarely discuss: the desire to protect our skin while craving the glow of a tan. It would also help to see celebrities and influencers embracing their natural skin tones, and for brands to do the same with the models in their campaigns. Whether it's a school session or a poster in a tanning salon, better education could also go a long way — not just about the dangers of sunbeds, which clearly isn't always enough, but about how to resist outside pressure. In learning how to accept ourselves as we are, we might just find the glow hits differently when it comes from within.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Could dental floss be the next way to receive vaccines? Scientists say open wide
Could dental floss be the next way to receive vaccines? Scientists say open wide

New York Post

time4 days ago

  • New York Post

Could dental floss be the next way to receive vaccines? Scientists say open wide

Dental floss could eventually do much more than improve oral hygiene. A new study led by Texas Tech University and the University of North Carolina suggests that the thin filament could eventually double as a vaccine mechanism. Advertisement In animal models, the researchers showed that dental floss can effectively release vaccines through the tissue between the teeth and gums, according to a press release. In the study, the flossing technique triggered the production of antibodies in 'mucosal surfaces,' such as the lining of the nose and lungs, the release stated. The findings were published in the journal Nature Biomedical Engineering. 'Mucosal surfaces are important because they are a source of entry for pathogens, such as influenza and COVID,' said co-author Harvinder Singh Gill, professor of chemical and biomolecular engineering at North Carolina State University, in the release. Advertisement With the traditional method of injecting vaccines, the antibodies are primarily produced in the bloodstream, he noted. 'But we know that when a vaccine is given via the mucosal surface, antibodies are stimulated not only in the bloodstream, but also on mucosal surfaces,' said Gill. 6 Dental floss could eventually do much more than improve oral hygiene, according to a new study. fStop – 'This improves the body's ability to prevent infection, because there is an additional line of antibody defense before a pathogen enters the body.' Advertisement The vaccine enters through the 'junctional epithelium,' which is a thin layer of tissue in the deep pocket between the tooth and the gum. This tissue doesn't have the same barrier as other tissue linings, which means it can release immune cells into the body. In the study, the researchers added a peptide flu vaccine to unwaxed dental floss before flossing the teeth of lab mice, according to the release. 6 With the traditional method of injecting vaccines, the antibodies are primarily produced in the bloodstream, he noted. Looker_Studio – Advertisement Next, they compared the effectiveness of the floss-delivered vaccine to techniques that delivered it nasally or orally. 'We found that applying vaccine via the junctional epithelium produces a far superior antibody response on mucosal surfaces than the current gold standard for vaccinating via the oral cavity, which involves placing vaccine under the tongue,' said first author Rohan Ingrole, a Ph.D. student at Texas Tech University. 'The flossing technique also provides comparable protection against the flu virus as compared to the vaccine being given via the nasal epithelium.' In addition to flu, the test was repeated for three other vaccine types: proteins, inactivated viruses, and mRNA. 6 'But we know that when a vaccine is given via the mucosal surface, antibodies are stimulated not only in the bloodstream, but also on mucosal surfaces,' said Harvinder Singh Gill, professor of chemical and biomolecular engineering at North Carolina State University. Pormezz – For all types, the flossing technique produced 'robust antibody responses in the bloodstream and across mucosal surfaces,' the release stated. Next, the research team aims to test the effectiveness of vaccine delivery to the epithelial junction in humans through the use of floss picks, which are easier to hold. 'It would be easy to administer, and it addresses concerns many people have about being vaccinated with needles,' Gill said. 'And we think this technique should be comparable in price to other vaccine delivery techniques.' Advertisement Start your day with all you need to know Morning Report delivers the latest news, videos, photos and more. Thanks for signing up! Enter your email address Please provide a valid email address. By clicking above you agree to the Terms of Use and Privacy Policy. Never miss a story. Check out more newsletters Hua Wang, assistant professor of materials science and engineering at the University of Illinois' Grainger College of Engineering, was not involved in the study but shared his reaction to the findings. 'This study presents a promising floss-based vaccination method that can avoid needle injection or any potentially painful procedure,' he told Fox News Digital. 'The authors demonstrated that vaccine components in the floss coating can penetrate the junctional epithelium in gingival sulcus and reach the underlying tissues, leading to systemic antibody responses.' Advertisement 6 The vaccine enters through the 'junctional epithelium,' which is a thin layer of tissue in the deep pocket between the tooth and the gum. Yuri A/ – The floss-based vaccination method could help to improve patient compliance if it goes through the full evaluation process, he noted. Limitations and future research There are some limitations and drawbacks associated with floss-based vaccines, the researchers acknowledged. Babies and toddlers who don't have teeth yet wouldn't be candidates for the technique, for example. Advertisement 6 The floss-based vaccination method could help to improve patient compliance if it goes through the full evaluation process, Hua Wang, assistant professor at the University of Illinois' Grainger College of Engineering, said. Shava Cueva/Stocksy – 'In addition, we would need to know more about how or whether this approach would work for people who have gum disease or other oral infections,' Gill added. Wang agreed that many questions remain to be answered about this experimental vaccination method. 'In addition to the unclear impact of gingival tissue infection on vaccination, the local and systemic side effects of this vaccination method remain to be understood,' he told Fox News Digital. Advertisement 'For example, vaccination at the gingival tissue may initiate local inflammation that eventually induces undesirable side effects.' 6 'In addition to the unclear impact of gingival tissue infection on vaccination, the local and systemic side effects of this vaccination method remain to be understood,' Wang continued. Science RF – It's also not yet clear what exact path the vaccine components follow when traveling from the tooth site to the tissues or how the immune responses are generated, Wang noted. 'Lastly, from the translation perspective, the efficacy of floss-based vaccines would need to be comparable to conventional needle-based vaccines.' The study was funded by the National Institutes of Health (NIH) and by funds from the Whitacre Endowed Chair in Science and Engineering at Texas Tech University.

You Could Receive COVID Vaccines via Dental Floss in Future
You Could Receive COVID Vaccines via Dental Floss in Future

Newsweek

time4 days ago

  • Newsweek

You Could Receive COVID Vaccines via Dental Floss in Future

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Vaccines given via dental floss could one day allow people to immunize themselves from COVID in the comfort of their own homes without having to use needles. This is the finding of North Carolina (NC) State University researchers who have demonstrated the new delivery method in an animal model—introducing a flu vaccine via the tissue between the teeth and gums. The novel approach has potential for broad application, the team says. "We expect the approach to work with COVID vaccine that uses mRNA, hepatitis and tetanus since they use subunit proteins as antigens, and other vaccines that use inactivated or attenuated viruses as antigens (such as MMR vaccine)," paper author and NC State nanomedicine professor Harvinder Singh Gill told Newsweek. "In essence through proper formulation of the coating, the approach should work with any vaccine." Woman holding a dental floss pick in her teeth. Woman holding a dental floss pick in her teeth. AndreyPopov/Getty Images The researchers discovered the new method stimulates the production of antibodies in mucosal surfaces—the moist linings of various body cavities— like the nose and lungs. "Mucosal surfaces are important, because they are a source of entry for pathogens, such as influenza and COVID," Gill said in a statement. "However, if a vaccine is given by injection, antibodies are primarily produced in the bloodstream throughout the body, and relatively few antibodies are produced on mucosal surfaces. "But we know that when a vaccine is given via the mucosal surface, antibodies are stimulated not only in the bloodstream, but also on mucosal surfaces. "This improves the body's ability to prevent infection, because there is an additional line of antibody defense before a pathogen enters the body." A health worker injects vaccine into patient's arm for Covid-19. A health worker injects vaccine into patient's arm for Covid-19. wisely/Getty Images Something called the 'junctional epithelium'—a thin layer of tissue that lines the surface of body parts—also played an important role in the study. While most epithelial tissues include robust barriers designed to keep 'bad' things like viruses and dirt from entering your blood stream, the junctional epithelium lacks such a barrier. This allows the junctional epithelium to release immune cells to fight bacteria, typically found in saliva and between teeth and gums. Gill explained, "The idea to use the junctional epithelium came through a chance reading in the literature that the 'junctional epithelium' is 'highly permeable'. The Gill lab has been working to develop mucosal vaccines for almost 20 years." He said the words 'highly permeable' were "like nectar" to him and "sparked an aha moment" because the mucosal tissues such as those in the gut, lungs and reproductive services are 'highly impermeable', making vaccine delivery challenging. This left him excited to test the new method out. "To our knowledge no one has ever used the junctional epithelium nor the floss for vaccine delivery," Gill added. Two light microscope images representing the junctional epithelium. Two light microscope images representing the junctional epithelium. JOSE LUIS CALVO MARTIN & JOSE ENRIQUE GARCIA-To assess the viability of delivering vaccines through the junctional epithelium, the researchers applied the vaccine to unwaxed dental floss and then flossed the teeth of mice. They compared antibody production in mice that received a peptide flu vaccine "via flossing the junctional epithelium; via the nasal epithelium; or via placing vaccine on the mucosal tissue under the tongue." "We found that applying vaccine via the junctional epithelium produces far superior antibody response on mucosal surfaces than the current gold standard for vaccinating via the oral cavity, which involves placing vaccine under the tongue," paper author Rohan Ingrole, who was a Ph.D. student under Gill at Texas Tech University, said in a statement. "The flossing technique also provides comparable protection against flu virus as compared to the vaccine being given via the nasal epithelium." "This is extremely promising, because most vaccine formulations cannot be given via the nasal epithelium—the barrier features in that mucosal surface prevent efficient uptake of the vaccine," added Gill. "Intranasal delivery also has the potential to cause the vaccine to reach the brain, which can pose safety concerns. However, vaccination via the junctional epithelium offers no such risk. "For this experiment, we chose one of the few vaccine formulations that actually works for nasal delivery because we wanted to see how junctional epithelium delivery compared to the best-case scenario for nasal delivery." The researchers also tested whether the junctional epithelium delivery method worked for three other prominent classes of vaccines—proteins, inactivated viruses and mRNA (a type of single-stranded RNA involved in protein synthesis, RNA being a key molecule found in living cells and viruses). The delivery technique produced "robust antibody responses" in the bloodstream and across mucosal surfaces in all three. Evident at least in the animal model, it didn't matter whether food and water was consumed immediately flossing with the vaccine—the immune response was the same. The researchers acknowledged, however, the impracticality of asking people to hold vaccine-coated floss in their fingers. This led them to introduce a floss pick with a handle, just like the one you might use for removing plaque and food particles. They coated the floss with fluorescent food dye, recruited 27 study participants, explained the new floss-based vaccine concept and asked them to try to deposit the food dye in their epithelial junction with a floss pick. Roughly 60 percent of the dye was deposited in the gum pocket, suggesting the floss pick may be a practical vaccine delivery method to the epithelial junction, according to the researchers. "For accessibility the advantage is that the vaccine is coated as a solid and thus it can be more stable and may not need cold storage. A floss could be self-administered, is painless and may receive better acceptance as compared to shots," said Gill. While more research is needed before the innovative method could be considered for clinical use, the researchers think the positives could extend beyond the improved antibody response—from ease of administration and easing vaccine concerns about needles to a comparable price. The CDC recommends an updated 2024–2025 COVID-19 vaccine for most adults 18 and older, while parents of children aged six months to 17 years should discuss the benefits of vaccination with a healthcare provider. However, six in 10 Americans said they would probably not get an updated 2024–2025 COVID-19 vaccine, according to an October Pew Research Center survey. Concern about side effects and feeling that the updated vaccine is personally unnecessary were the top two reasons why people were reluctant—regardless of age, party, or race and ethnicity. A smaller share of those not planning to get an updated vaccine said a major reason why is that they generally don't get vaccines. Very few cited cost as a major reason, according to the survey. Some drawbacks of the potential floss-vaccine to consider include that it wouldn't work on infants and toddlers without teeth and whether it would work for people with gum disease or other oral infections. What about side effects? "This requires more study. The anticipation is that the side effects may not be any greater than conventional shots," said Gill. "Next, the approach should be tested on larger animals such as pigs. Additional engineering is also needed to improve upon the device itself so that it is more user friendly. In the long-term, our vision is that this could be a kit either used in the comfort of home, or a dentist's office, or pharmacies." Do you have a tip on a health story that Newsweek should be covering? Do you have a question about vaccination? Let us know via health@ Reference Ingrole, R. S. J., Shakya, A. K., Joshi, G., Lee, C. H., Nesovic, L. D., Compans, R. W., & Gill, H. S. (2025). Floss-based vaccination targets the gingival sulcus for mucosal and systemic immunization. Nature Biomedical Engineering.

J.P. Morgan Weighs In on UnitedHealth Stock Amid DOJ Scrutiny
J.P. Morgan Weighs In on UnitedHealth Stock Amid DOJ Scrutiny

Business Insider

time26-07-2025

  • Business Insider

J.P. Morgan Weighs In on UnitedHealth Stock Amid DOJ Scrutiny

UnitedHealth (NYSE:UNH) stock slipped again on Thursday, a familiar pattern in what's shaping up to be a rough year. Shares have tumbled 44% year-to-date, weighed down by a string of negative developments, including disappointing Q1 results, a CEO change, the suspension of guidance, and rising costs tied to UHC's Medicare Advantage members. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Thursday's 5% drop was driven by renewed scrutiny over an ongoing legal matter. UNH disclosed that it had proactively reached out to the DOJ following a February Wall Street Journal report revealing a civil investigation into its Medicare Advantage risk-coding practices. In its latest filing, the company confirmed that it is now responding to formal civil and criminal inquiries, has launched its own internal review, and remains cooperative with CMS audits. UNH also pointed to a favorable March ruling from a Special Master in a separate, long-running DOJ civil case as a sign of how past challenges have played out. This shift from 'unaware' in February to 'proactively cooperating' now isn't surprising to J.P. Morgan analyst Lisa Gill, who views the company's engagement as part of a broader defense of its practices. 'While we are not lawyers,' Gill noted, 'we note that if the court were to view this case similarly to previous ones brought forth by DOJ regarding the False Claims Act (FCA), we believe that this would place the burden of proof on the DOJ to prove improper coding.' Though the investigation has added another layer of uncertainty, Gill contextualizes it within broader industry trends. The analyst points to risk-adjustment programs like RADV and regulatory updates like V28 as ongoing efforts to refine coding practices across the Medicare Advantage landscape. Viewed through that lens, the current probes may ultimately reflect how companies have adapted, rather than acted improperly. Still, Gill acknowledges the ambiguity facing investors. The company's filing offers limited detail, and any legal proceedings stemming from the DOJ's inquiries are likely to be drawn out. Much could hinge on the outcome of the ongoing DOJ-backed civil case – one in which the Special Master recently recommended dismissal due to lack of evidence, though the DOJ has challenged that recommendation. In the meantime, Gill is looking ahead to next week's earnings call for added clarity, and remains optimistic. The analyst assigns UNH an Overweight (i.e., Buy) rating and $418 price target, suggesting the stock could rebound by 48% over the next 12 months. (To watch Gill's track record, click here) And she's not alone. 17 other analysts share Gill's bullish outlook, while 5 remain on the sidelines and just one is bearish. Altogether, the stock carries a Moderate Buy consensus rating. The average price target stands at $348.12, implying a ~24% upside from current levels. (See UNH stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store